- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2024
- 189 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 272 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2024
- 125 Pages
Global
From €5656EUR$5,950USD£4,752GBP
In the healthcare services sector, the Clinical Nutrition for Cancer Care market encompasses products and services dedicated to addressing the nutritional needs of cancer patients. Cancer care often necessitates specialized nutrition plans to help patients maintain their strength, manage treatment side effects, and improve their quality of & life. Malnutrition and weight loss are common in cancer patients, affecting treatment efficacy and survival rates. Therefore, clinical nutrition in cancer care includes enteral and parenteral nutrition, dietary supplements, and counseling from dietitians or nutritional specialists who develop personalized nutrition strategies.
Clinical nutrition products range from high-calorie, protein-rich shakes to micronutrient supplements, and they are designed to meet the unique requirements of cancer patients undergoing chemotherapy, radiation, or surgery. Companies in this market are engaged in research and development of new formulations that align with the latest clinical guidelines and patient needs, and often collaborate with healthcare institutions to provide comprehensive nutritional care.
Some companies and entities that operate within the Clinical Nutrition for Cancer Care market include Abbott Nutrition, Nestle Health Science, Danone Nutricia, Fresenius Kabi, and B. Braun. These organizations produce a range of nutritional products specifically tailored for oncology patients and are key players in advancing the field of nutritional support for cancer care. Show Less Read more